Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin vs Tamsulosin for Distal Ureteric Calculi
NCT05790902Phase 1Completed
- Sponsor
- Armed Forces Institute of Urology
- Start
- Sep 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of silodosin in ureteral calculus (2 arms), sponsored by Armed Forces Institute of Urology. Primary endpoint: Stone clearance rate at 4 weeks. Started Sep 2022; status: completed.
02
Drugs
silodosin
03
Conditions
ureteral calculus
Beyond the preview
Go deeper on NCT05790902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05790902.